CA1084051A - 3,4-dihydro-quinazoline derivatives and process for their preparation - Google Patents

3,4-dihydro-quinazoline derivatives and process for their preparation

Info

Publication number
CA1084051A
CA1084051A CA267,090A CA267090A CA1084051A CA 1084051 A CA1084051 A CA 1084051A CA 267090 A CA267090 A CA 267090A CA 1084051 A CA1084051 A CA 1084051A
Authority
CA
Canada
Prior art keywords
dihydro
carboxy
quinazoline
oxo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA267,090A
Other languages
English (en)
French (fr)
Inventor
Gianfederico Doria
Francesco Lauria
Maria L. Corno
Ciriaco Romeo
Piernicola Giraldi
Marcello Tibolla
Piero Sberze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of CA1084051A publication Critical patent/CA1084051A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA267,090A 1975-12-05 1976-12-03 3,4-dihydro-quinazoline derivatives and process for their preparation Expired CA1084051A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT29998/75A IT1050750B (it) 1975-12-05 1975-12-05 Derivati della 3.4 di idro chinazolina
IT29998A/75 1975-12-05

Publications (1)

Publication Number Publication Date
CA1084051A true CA1084051A (en) 1980-08-19

Family

ID=11228830

Family Applications (1)

Application Number Title Priority Date Filing Date
CA267,090A Expired CA1084051A (en) 1975-12-05 1976-12-03 3,4-dihydro-quinazoline derivatives and process for their preparation

Country Status (22)

Country Link
US (1) US4251531A (enExample)
JP (1) JPS5271485A (enExample)
AT (1) AT355029B (enExample)
AU (1) AU505660B2 (enExample)
BE (1) BE848696A (enExample)
CA (1) CA1084051A (enExample)
CH (2) CH626073A5 (enExample)
CS (1) CS194786B2 (enExample)
DE (1) DE2654215A1 (enExample)
DK (1) DK147855C (enExample)
FI (1) FI64359C (enExample)
FR (1) FR2333511A1 (enExample)
GB (1) GB1523081A (enExample)
HU (1) HU177817B (enExample)
IL (1) IL50849A (enExample)
IT (1) IT1050750B (enExample)
NL (1) NL7613450A (enExample)
NO (1) NO146095C (enExample)
NZ (1) NZ182778A (enExample)
SE (1) SE7613588L (enExample)
SU (1) SU786894A3 (enExample)
ZA (1) ZA766745B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
US6632961B1 (en) * 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
CA2332535C (en) * 1998-05-22 2006-02-28 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
US7893071B2 (en) * 2001-04-23 2011-02-22 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic
CN101152185B (zh) * 2003-06-06 2010-12-08 阿里克斯股份公司 杂环化合物作为scce抑制剂的用途
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
KR101419075B1 (ko) * 2006-08-08 2014-07-11 아스카 세이야쿠 가부시키가이샤 퀴나졸린 유도체
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
NZ617779A (en) 2009-03-18 2015-08-28 Resverlogix Corp Novel anti-inflammatory agents
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
CN114984016A (zh) 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
GB201510254D0 (en) * 2015-06-12 2015-07-29 Syngenta Participations Ag Improvements in or relating to organic compounds
WO2020004594A1 (ja) * 2018-06-27 2020-01-02 株式会社リボルナバイオサイエンス 脊髄性筋萎縮症の予防または治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696102A (en) 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones
GB1301319A (enExample) 1970-07-13 1972-12-29

Also Published As

Publication number Publication date
ATA894376A (de) 1979-07-15
NO146095B (no) 1982-04-19
ZA766745B (en) 1977-10-26
FI64359B (fi) 1983-07-29
IL50849A (en) 1980-11-30
SE7613588L (sv) 1977-06-06
FR2333511B1 (enExample) 1979-03-02
AU1947276A (en) 1978-05-18
DK147855C (da) 1985-06-10
DK546776A (da) 1977-06-06
AU505660B2 (en) 1979-11-29
NL7613450A (nl) 1977-06-07
IL50849A0 (en) 1977-01-31
FR2333511A1 (fr) 1977-07-01
BE848696A (fr) 1977-03-16
NZ182778A (en) 1978-07-28
US4251531A (en) 1981-02-17
CS194786B2 (en) 1979-12-31
GB1523081A (en) 1978-08-31
DK147855B (da) 1984-12-24
CH626073A5 (enExample) 1981-10-30
CH626075A5 (enExample) 1981-10-30
FI763391A7 (enExample) 1977-06-06
SU786894A3 (ru) 1980-12-07
HU177817B (en) 1981-12-28
JPS5271485A (en) 1977-06-14
NO146095C (no) 1982-08-11
NO764135L (enExample) 1977-06-07
AT355029B (de) 1980-02-11
JPS5543464B2 (enExample) 1980-11-06
IT1050750B (it) 1981-03-20
FI64359C (fi) 1983-11-10
DE2654215A1 (de) 1977-06-16

Similar Documents

Publication Publication Date Title
US4251531A (en) 3,4-Dihydro-quinazoline derivatives
US3702849A (en) 4-(isoquinolin-1-yl) piperazine-1-carboxylic acid esters
US4159330A (en) 2-Disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation
CA1115272A (en) 4-amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8- naphthyridine derivatives
US4284768A (en) 1,2-Dihydro-4-amino-2-oxo-3-quinoline-carboxylic acid derivatives
EP0011142B1 (de) Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
NO151287B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidinderivater
SE444938B (sv) 5-karboxi-2h-bensofuran-3-on-derivat
US4299963A (en) 1-Azaxanthone derivatives
DE68924308T2 (de) Pyridazinon-Derivate.
US3627766A (en) 5,6,7,8-TETRAHYDRO-PYRIDO{8 4{40 ,3{40 :4,5{9 THIENO{8 2,3-d{9 PYRIMIDINES
US4012387A (en) Benzo-[g]pyrido[2,1-b]quinazolinones
US4419357A (en) 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CA1092118A (en) 2-disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation
Honma et al. Antiallergic agents. 3. N-(1H-tetrazol-5-yl)-2-pyridinecarboxamides
CH616934A5 (en) Process for the preparation of chromone derivatives
US3974161A (en) Fused pyrimidin-4(3H)-ones as antiallergy agents
CA1073905A (en) Pyrazolo (1,5-a) pyrido (3,2-e) pyrimidine-7-carboxylic acid derivatives
US3214429A (en) Quinazolinones and process for preparing
US4071516A (en) 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones
US3291824A (en) Nu-(2-halo-lower alkanoyl) anthranilic acid derivatives
KUNo et al. Studies on cerebral protective agents. IV. Synthesis of novel 4-arylpyridine and 4-arylpyridazine derivatives with anti-anoxic activity
US4120962A (en) Fused pyrimidin-4(3H)-ones as antiallergy agents
SE443785B (sv) Substituerade 2-cyklopropylkromoner
Varma et al. Synthesis of some 6-bromo-3-[(arylamino) methyl]-and 2-styryl-3-[4'-(carboalkoxy) phenyl]-4 (3H)-quinazolinones

Legal Events

Date Code Title Description
MKEX Expiry